Breast Cancer Screening Market 2027 by Screening Test, End User | The Insight Partners

Breast Cancer Screening Market to 2027 - Global Analysis and Forecasts by Screening Test (Mammography, Magnetic Resonance Imaging, Ultrasound, Others); End User (Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories)

Report Code: TIPRE00009796 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Breast cancer is the most common and widely occurring type of cancer among women that forms in tissues of the breast, usually in the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It can also occur in the fatty tissue or the fibrous connective tissue within your breast. Early diagnosis of breast cancer is important as it may prevent the condition from becoming critical and ensure a successful curable treatment. The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage. The screening procedure identifies the early signs of cancer, even before the symptoms begin to show.

MARKET DYNAMICS

The rising number of breast cancer cases and growing awareness on preventive checkup for breast cancers will drive the growing demand of the breast cancer screening market. The growing demand for regular monitoring devices & systems for early cancer detection combined with the higher expenditure on healthcare by people, is another chief growth augmenting factor that will affect the breast cancer screening market. However, harmful effects of screening procedures and screening procedures for breast cancer are highly expensive which may hinder the growth of the market in the forecasted period.

MARKET SCOPE

The "Global Breast cancer screening Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of breast cancer screening market with detailed market segmentation by screening test, end-user, and geography. The global Breast cancer screening Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading breast cancer screening market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global breast cancer screening market is segmented on the screening test, and end-user. Based on screening test, the global breast cancer screening market is segmented into mammography, magnetic resonance imaging, ultrasound and others. Based on the end-user, the breast cancer screening market is segmented into hospitals, clinics, ambulatory surgical centers, cancer research institutes and diagnostics laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global breast cancer screening market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The breast cancer screening market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting breast cancer screening market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the breast cancer screening market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the breast cancer screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from breast cancer screening market are anticipated to lucrative growth opportunities in the future with the rising demand for breast cancer screening in the global market. Below mentioned is the list of few companies engaged in the breast cancer screening market.

The report also includes the profiles of key breast cancer screening market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Siemens Healthcare Private Limited
  •  Hologic, Inc.
  •  Koninklijke Philips N.V.
  •  CANON MEDICAL SYSTEMS CORPORATION
  •  FUJIFILM Holdings Corporation
  •  Metaltronica S.p.A.
  •  SINO MDT
  •  GENERAL ELECTRIC COMPANY
  •  PLANMED OY
  •  Carestream Health


The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Breast Cancer Screening Market - By Screening Test
1.3.2 Breast Cancer Screening Market - By End User
1.3.3 Breast Cancer Screening Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BREAST CANCER SCREENING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BREAST CANCER SCREENING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. BREAST CANCER SCREENING MARKET - GLOBAL MARKET ANALYSIS
6.1. BREAST CANCER SCREENING - GLOBAL MARKET OVERVIEW
6.2. BREAST CANCER SCREENING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BREAST CANCER SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - SCREENING TEST
7.1. OVERVIEW
7.2. SCREENING TEST MARKET FORECASTS AND ANALYSIS
7.3. MAMMOGRAPHY
7.3.1. Overview
7.3.2. Mammography Market Forecast and Analysis
7.4. MAGNETIC RESONANCE IMAGING
7.4.1. Overview
7.4.2. Magnetic Resonance Imaging Market Forecast and Analysis
7.5. ULTRASOUND
7.5.1. Overview
7.5.2. Ultrasound Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. BREAST CANCER SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.6. CANCER RESEARCH INSTITUTES
8.6.1. Overview
8.6.2. Cancer Research Institutes Market Forecast and Analysis
8.7. DIAGNOSTIC LABORATORIES
8.7.1. Overview
8.7.2. Diagnostic Laboratories Market Forecast and Analysis
9. BREAST CANCER SCREENING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Breast Cancer Screening Market Overview
9.1.2 North America Breast Cancer Screening Market Forecasts and Analysis
9.1.3 North America Breast Cancer Screening Market Forecasts and Analysis - By Screening Test
9.1.4 North America Breast Cancer Screening Market Forecasts and Analysis - By End User
9.1.5 North America Breast Cancer Screening Market Forecasts and Analysis - By Countries
9.1.5.1 United States Breast Cancer Screening Market
9.1.5.1.1 United States Breast Cancer Screening Market by Screening Test
9.1.5.1.2 United States Breast Cancer Screening Market by End User
9.1.5.2 Canada Breast Cancer Screening Market
9.1.5.2.1 Canada Breast Cancer Screening Market by Screening Test
9.1.5.2.2 Canada Breast Cancer Screening Market by End User
9.1.5.3 Mexico Breast Cancer Screening Market
9.1.5.3.1 Mexico Breast Cancer Screening Market by Screening Test
9.1.5.3.2 Mexico Breast Cancer Screening Market by End User
9.2. EUROPE
9.2.1 Europe Breast Cancer Screening Market Overview
9.2.2 Europe Breast Cancer Screening Market Forecasts and Analysis
9.2.3 Europe Breast Cancer Screening Market Forecasts and Analysis - By Screening Test
9.2.4 Europe Breast Cancer Screening Market Forecasts and Analysis - By End User
9.2.5 Europe Breast Cancer Screening Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Breast Cancer Screening Market
9.2.5.1.1 Germany Breast Cancer Screening Market by Screening Test
9.2.5.1.2 Germany Breast Cancer Screening Market by End User
9.2.5.2 France Breast Cancer Screening Market
9.2.5.2.1 France Breast Cancer Screening Market by Screening Test
9.2.5.2.2 France Breast Cancer Screening Market by End User
9.2.5.3 Italy Breast Cancer Screening Market
9.2.5.3.1 Italy Breast Cancer Screening Market by Screening Test
9.2.5.3.2 Italy Breast Cancer Screening Market by End User
9.2.5.4 Spain Breast Cancer Screening Market
9.2.5.4.1 Spain Breast Cancer Screening Market by Screening Test
9.2.5.4.2 Spain Breast Cancer Screening Market by End User
9.2.5.5 United Kingdom Breast Cancer Screening Market
9.2.5.5.1 United Kingdom Breast Cancer Screening Market by Screening Test
9.2.5.5.2 United Kingdom Breast Cancer Screening Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Breast Cancer Screening Market Overview
9.3.2 Asia-Pacific Breast Cancer Screening Market Forecasts and Analysis
9.3.3 Asia-Pacific Breast Cancer Screening Market Forecasts and Analysis - By Screening Test
9.3.4 Asia-Pacific Breast Cancer Screening Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Breast Cancer Screening Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Breast Cancer Screening Market
9.3.5.1.1 Australia Breast Cancer Screening Market by Screening Test
9.3.5.1.2 Australia Breast Cancer Screening Market by End User
9.3.5.2 China Breast Cancer Screening Market
9.3.5.2.1 China Breast Cancer Screening Market by Screening Test
9.3.5.2.2 China Breast Cancer Screening Market by End User
9.3.5.3 India Breast Cancer Screening Market
9.3.5.3.1 India Breast Cancer Screening Market by Screening Test
9.3.5.3.2 India Breast Cancer Screening Market by End User
9.3.5.4 Japan Breast Cancer Screening Market
9.3.5.4.1 Japan Breast Cancer Screening Market by Screening Test
9.3.5.4.2 Japan Breast Cancer Screening Market by End User
9.3.5.5 South Korea Breast Cancer Screening Market
9.3.5.5.1 South Korea Breast Cancer Screening Market by Screening Test
9.3.5.5.2 South Korea Breast Cancer Screening Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Breast Cancer Screening Market Overview
9.4.2 Middle East and Africa Breast Cancer Screening Market Forecasts and Analysis
9.4.3 Middle East and Africa Breast Cancer Screening Market Forecasts and Analysis - By Screening Test
9.4.4 Middle East and Africa Breast Cancer Screening Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Breast Cancer Screening Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Breast Cancer Screening Market
9.4.5.1.1 South Africa Breast Cancer Screening Market by Screening Test
9.4.5.1.2 South Africa Breast Cancer Screening Market by End User
9.4.5.2 Saudi Arabia Breast Cancer Screening Market
9.4.5.2.1 Saudi Arabia Breast Cancer Screening Market by Screening Test
9.4.5.2.2 Saudi Arabia Breast Cancer Screening Market by End User
9.4.5.3 U.A.E Breast Cancer Screening Market
9.4.5.3.1 U.A.E Breast Cancer Screening Market by Screening Test
9.4.5.3.2 U.A.E Breast Cancer Screening Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Breast Cancer Screening Market Overview
9.5.2 South and Central America Breast Cancer Screening Market Forecasts and Analysis
9.5.3 South and Central America Breast Cancer Screening Market Forecasts and Analysis - By Screening Test
9.5.4 South and Central America Breast Cancer Screening Market Forecasts and Analysis - By End User
9.5.5 South and Central America Breast Cancer Screening Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Breast Cancer Screening Market
9.5.5.1.1 Brazil Breast Cancer Screening Market by Screening Test
9.5.5.1.2 Brazil Breast Cancer Screening Market by End User
9.5.5.2 Argentina Breast Cancer Screening Market
9.5.5.2.1 Argentina Breast Cancer Screening Market by Screening Test
9.5.5.2.2 Argentina Breast Cancer Screening Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BREAST CANCER SCREENING MARKET, KEY COMPANY PROFILES
11.1. SIEMENS HEALTHCARE PRIVATE LIMITED
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. HOLOGIC, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. KONINKLIJKE PHILIPS N.V.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CANON MEDICAL SYSTEMS CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. FUJIFILM HOLDINGS CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. METALTRONICA S.P.A.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SINO MDT
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GENERAL ELECTRIC COMPANY
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PLANMED OY
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CARESTREAM HEALTH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Siemens Healthcare Private Limited
2. Hologic, Inc.
3. Koninklijke Philips N.V.
4. CANON MEDICAL SYSTEMS CORPORATION
5. FUJIFILM Holdings Corporation
6. Metaltronica S.p.A.
7. SINO MDT
8. GENERAL ELECTRIC COMPANY
9. PLANMED OY
10. Carestream Health
TIPRE00009796
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking